Status:
COMPLETED
The Pan African Pulmonary Hypertension Cohort Study
Lead Sponsor:
University of Cape Town
Collaborating Sponsors:
Doula General Hospital, Cameroon
Instituto Nacional de Saúde, Mozambique
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
1+ years
Brief Summary
The study will recruit and follow up patients for six months patients newly diagnosed with pulmonary hypertension from twelve centers across four countries; South Africa, Mozambique, Cameroon, Nigeria...
Detailed Description
Title: Implementation of the PAPUCO Registry Background to PAPUCO Registry The Sub-Saharan Task Force on Pulmonary Hypertension, under the leadership of Dr Ana Olga Mocumbi and Prof. Sliwa, was esta...
Eligibility Criteria
Inclusion
- Patients of any age who meet clinical and echocardiographic criteria for the diagnosis of PHT will be included
Exclusion
- Patients who are unable, or unlikely, to return for 6 month follow-up will be excluded
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
254 Patients enrolled
Trial Details
Trial ID
NCT02265887
Start Date
June 1 2012
End Date
June 1 2015
Last Update
August 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cape Town
Cape Town, Western Cape, South Africa, 7925